New Haven biotech Arvinas is expanding its footprint at Yale’s Science Park by 10,000 square feet to make room for a wave of new hires. Arvinas, which is developing treatments for prostate and breast cancer, has extended its main lease at 5 Science Park, as well as another at 4 Science Park
The biotech, founded by Yale scientist Dr. Craig Crews, has been steadily growing. CEO John Houston said that the latest expansion will allow for additional lab space to meet the needs of the company’s growing headcount.